Fibroblast Growth Factor 19 Levels Predict Subclinical Atherosclerosis in Men With Type 2 Diabetes
Objective: Fibroblast growth factor 19 (FGF19) plays an indispensable role in regulating bile acid, glucose, and lipid metabolism, and alterations of its circulating concentration is associated with the development of type 2 diabetes (T2D). Atherosclerosis is directly related to the death-deriving d...
Main Authors: | Jingyi Hu, Zhiwen Liu, Yue Tong, Zubing Mei, Aimin Xu, Pengcheng Zhou, Xiaoyan Chen, Weili Tang, Zhiguang Zhou, Yang Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2020.00282/full |
Similar Items
-
Association between microalbuminuria and subclinical atherosclerosis evaluated by carotid artery intima-media in elderly patients with normal renal function
by: Kong XiangLei, et al.
Published: (2012-06-01) -
Evaluation of subclinical atherosclerosis in chronic sinusitis patients
by: Musa Çakıcı, et al.
Published: (2015-04-01) -
Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients
by: Mo Yifei, et al.
Published: (2013-01-01) -
The Usefulness of High-Resolution Carotid Ultrasonography for the Detection of Subclinical Atherosclerosis
by: Neskubina OM, et al.
Published: (2015-10-01) -
Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism
by: Hamiyet Yilmaz Yasar, et al.